Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population
- 1 July 2016
- journal article
- Published by Elsevier in European Urology
- Vol. 70 (1) , 6-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A genetic-based approach to personalized prostate cancer screening and treatmentCurrent Opinion in Urology, 2015
- Serum markers in prostate cancer detectionCurrent Opinion in Urology, 2015
- Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association StudiesCancer Epidemiology, Biomarkers & Prevention, 2014
- Early Detection of Prostate Cancer: European Association of Urology RecommendationEuropean Urology, 2013
- Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levelsHuman Genetics, 2011
- Impact of Genotyping on Outcome of Prostatic Biopsies: A Multicenter Prospective StudyMolecular Medicine, 2011
- Genetic Correction of PSA Values Using Sequence Variants Associated with PSA LevelsScience Translational Medicine, 2010
- Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancerThe Prostate, 2008
- Impact de l’obésité sur le PSA lors du dépistage du cancer de la prostateProgrès en Urologie, 2007
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24Nature Genetics, 2007